Cytek Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.03 | -$0.02 | -$0.03 |
| Q2 2024 | 0 | -$0.00 | -$0.00 | -$0.00 |
| Q3 2024 | 3 | -$0.02 | $0.06 | $0.02 |
| Q4 2024 | 0 | $0.06 | $0.07 | $0.07 |
| Q1 2025 | 2 | -$0.00 | -$0.00 | -$0.00 |
| Q2 2025 | 2 | $0.02 | $0.02 | $0.02 |
| Q3 2025 | 2 | $0.04 | $0.04 | $0.04 |
| Q4 2025 | 2 | $0.08 | $0.09 | $0.09 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.02 | $0.02 | $0.02 |
| Q3 2026 | 0 | $0.03 | $0.04 | $0.03 |
| Q4 2026 | 0 | $0.09 | $0.10 | $0.10 |
Cytek Biosciences, Inc. Earnings Date And Information
Cytek Biosciences, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.03 by $0.05. The company had revenue of 46.62 M for the quarter and had revenue of 193.02 M for the year. Cytek Biosciences, Inc. has generated $0 earnings per share over the last year ($-0.0898 diluted earnings per share) and currently has a price-to-earnings ratio of -41.48. Cytek Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Cytek Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | -$0.03 | -$0.08 | -0.05 | $49.53 M | $46.62 M |
| 05/08/2024 | Q1 2024 | -$0.05 | -$0.05 | 0 | $44.86 M | |
| 03/13/2024 | Q4 2023 | $0.03 | $0.04 | 0.01 | $58.23 M | |
| 11/14/2023 | Q3 2023 | -$0.05 | $55.48 M | $48.00 M | ||
| 08/08/2023 | Q2 2023 | -$0.01 | -$0.03 | -0.02 | $45.71 M | $49.69 M |
| 05/09/2023 | Q1 2023 | -$0.02 | -$0.05 | -0.04 | $37.09 M | |
| 03/01/2023 | Q4 2022 | $0.03 | $48.34 M | |||
| 11/09/2022 | Q3 2022 | $0.02 | $0.01 | -0.01 | $43.29 M | $40.48 M |
| 08/10/2022 | Q2 2022 | $0.02 | -$0.00 | -0.02 | $40.16 M | |
| 05/11/2022 | Q1 2022 | -$0.02 | $35.06 M | |||
| 03/17/2022 | Q4 2021 | $0.00 | $36.42 M | $38.89 M | ||
| 11/12/2021 | Q3 2021 | $0.01 | $33.37 M | $34.38 M | ||
| 09/02/2021 | Q2 2021 | $0.02 | $28.27 M | $30.41 M | ||
| 03/30/2021 | Q1 2021 | $0.00 | $24.27 M | |||
| 12/30/2020 | Q4 2020 | $0.05 | $30.62 M | |||
| 09/29/2020 | Q3 2020 | $0.21 | $25.10 M | |||
| 06/29/2020 | Q2 2020 | $0.26 | $19.14 M | |||
| 03/30/2020 | Q1 2020 | -$0.01 | $17.99 M |
Cytek Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Cytek Biosciences, Inc.'s earnings date?
Cytek Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Cytek Biosciences, Inc.'s earnings conference call?
The conference call for Cytek Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Cytek Biosciences, Inc.'s conference call transcript?
The conference call transcript for Cytek Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Cytek Biosciences, Inc. generate each year?
Cytek Biosciences, Inc. (:CTKB) has a recorded annual revenue of $193.02 M.
-
How much profit does Cytek Biosciences, Inc. generate each year?
Cytek Biosciences, Inc. (:CTKB) has a recorded net income of $193.02 M. Cytek Biosciences, Inc. has generated $-0.0898 earnings per share over the last four quarters.
-
What is Cytek Biosciences, Inc.'s price-to-earnings ratio?
Cytek Biosciences, Inc. (:CTKB) has a price-to-earnings ratio of -41.48 and price/earnings-to-growth ratio is 0.07.
